Clarence Harris Foundation

Clarence Harris FoundationClarence Harris FoundationClarence Harris Foundation

Clarence Harris Foundation

Clarence Harris FoundationClarence Harris FoundationClarence Harris Foundation
  • Home
  • About
  • Education
  • Events
  • Donate
  • Contact
  • More
    • Home
    • About
    • Education
    • Events
    • Donate
    • Contact
Donate
  • Home
  • About
  • Education
  • Events
  • Donate
  • Contact
Donate

What You Need to Know About Screening

Prostate cancer is one of the most treatable cancers when caught early. The most powerful thing a man can do is get informed -- and get screened.

Early Detection Changes Everything

99%

1 in 8

1 in 8

5-year survival rate when caught at the local or regional stage

1 in 8

1 in 8

1 in 8

Men will be diagnosed with prostate cancer in their lifetime

1 in 6

1 in 6

1 in 6

Black men will be diagnosed -- nearly twice the national average

Age 40

1 in 6

1 in 6

When Black men and high-risk individuals should begin screening conversations 

What Is Prostate Cancer Screening?

PSA Blood Test

Digital Rectal Exam (DRE)

Digital Rectal Exam (DRE)

The PSA (Prostate Specific Antigen) test measures the level of PSA in your blood. PSA is a protein that is produced by the prostate gland. Elevated PSA can be a sign of prostate cancer, though other conditions can also raise PSA. It is a simple blood draw —  fast, routine, and widely available.

Digital Rectal Exam (DRE)

Digital Rectal Exam (DRE)

Digital Rectal Exam (DRE)

A DRE allows a doctor to physically examine the prostate gland for abnormalities in size, shape, or texture. It is often done alongside a PSA test. While brief and straightforward, it provides information the PSA test alone cannot.

Screening Recommendation by Risk Level

Average Risk (Start at age 50)

High Risk -- Black Men (Start at age 40-45)

High Risk -- Black Men (Start at age 40-45)

Men at average risk with no family history of prostate cancer and who are not Black should discuss screening with their doctor starting at age 50.

High Risk -- Black Men (Start at age 40-45)

High Risk -- Black Men (Start at age 40-45)

High Risk -- Black Men (Start at age 40-45)

Black men are significantly more likely to develop prostate cancer and to be diagnosed at a younger age. Screening conversations should begin at age 40 to 45.

High Risk - Family History (start at age 40-45)

High Risk - Family History (start at age 40-45)

High Risk - Family History (start at age 40-45)

Men with a father, brother, or son diagnosed with prostate cancer -- especially before age 65 -- are at higher risk and should begin screening discussions earlier

Very High Risk (Discuss with your doctor)

High Risk - Family History (start at age 40-45)

High Risk - Family History (start at age 40-45)

Men with multiple first-degree relatives affected, or those with known BRCA gene mutations, should speak with their doctor about a personalized screening plan

We hear these questions a lot

Yes. Early-stage prostate cancer almost never causes symptoms. By the time symptoms appear, the cancer may have already spread. Feeling healthy is not the same as being cancer-free


The PSA test is a simple blood draw —  no difference from any routine lab work. A DRE is brief and may cause mild discomfort, but it is over in seconds. Neither test should stop you from getting screened.  


An elevated PSA does not automatically mean cancer. Many things can raise PSA levels. Your doctor will guide you through next steps, which may include a follow-up test or a referral to a specialist. Knowledge is always better than uncertainty.


We understand that access is a real barrier. That is why the Clarence Harris Foundation works to bring free and low cost screening events directly into communities. 


Clarence Harris Foundation

Copyright © 2026 Clarence Harris Foundation - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept